Holen Sie sich die Stockscreener-App
138.90
1.53%
-2.165
Schlusskurs vom Vortag:
$141.06
Offen:
$142.05
24-Stunden-Volumen:
1.20M
Relative Volume:
0.95
Marktkapitalisierung:
$18.97B
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$-214.69M
KGV:
-78.92
EPS:
-1.76
Netto-Cashflow:
$-43.68M
1W Leistung:
+0.00%
1M Leistung:
-15.39%
6M Leistung:
-17.13%
1J Leistung:
+35.98%
1-Tages-Spanne:
$138.24
$143.36
1-Wochen-Bereich:
$136.91
$144.00
52-Wochen-Spanne:
$92.14
$183.00
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Vergleichen Sie NTRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
138.90 | 19.26B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
478.32 | 179.32B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.48 | 145.22B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
565.19 | 44.23B | 3.93B | 894.97M | 837.70M | 10.82 |
|
IQV
Iqvia Holdings Inc
|
199.17 | 34.14B | 15.50B | 1.33B | 2.16B | 7.34 |
|
A
Agilent Technologies Inc
|
120.18 | 34.19B | 6.63B | 1.17B | 1.19B | 4.05 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
RBC Capital Maintains a Buy on Natera (NTRA) With a $251 PT - Insider Monkey
10 Best Strong Buy Healthcare Stocks to Buy Now - Insider Monkey
What analysts say about Natera Inc. stockTriple-digit growth rates - PrintWeekIndia
U.S. Minimal Residual Disease Testing Market Trends Analysis Report 2025-2033 | Integration with Personalized Medicines, & Rising Incidence and Prevalence of Hematological Malignancies Fueling Growth - GlobeNewswire Inc.
What institutions are buying Natera Inc. stock nowHigh-yield capital appreciation - jammulinksnews.com
Natera CFO Brophy sold $303k in NTRA stock - Investing.com Australia
Natera's Prospera™ Heart with DQS: A Game-Changer in Transplant Monitoring - AInvest
PEDAL Study Successful, Shows Monitoring with Prospera™ Kidney Provides Accurate Prognosis of Long-Term Clinical Outcomes Following Rejection; Now Published in AJT - Yahoo Finance
Natera(NTRA) Plunges 1.50% Amid Insider Sales - AInvest
Natera Inc. Stock Analysis and ForecastFree Stock Movement Tracking - Autocar Professional
SEC Filings Archive 2025-07-22Historical 10-K, 10-Q, 8-K Forms - Stock Titan
Natera CFO Brophy sold $83,852 in NTRA stock - Investing.com Australia
Natera CEO Chapman sells $225,928 in shares - Investing.com
Natera director Sheena Jonathan sells $12953 in shares - Investing.com Australia
Natera president Fesko sells $273k in stock - Investing.com Australia
Natera Inc: President Moshkevich sells $299k in shares - Investing.com
Natera president Fesko sells $273k in stock By Investing.com - Investing.com UK
Natera’s chief legal officer sells $3.4 million in stock - Investing.com
What drives Natera Inc. stock priceMarket-beating returns - jammulinksnews.com
Is Natera Inc. a good long term investmentMassive portfolio appreciation - jammulinksnews.com
Natera director Sheena Jonathan sells $460k in stock By Investing.com - Investing.com Nigeria
Natera director Sheena Jonathan sells $460k in stock - Investing.com
Natera(NTRA) Shares Plunge 3.12% Amid Market, Regulatory Challenges - AInvest
When the Price of (NTRA) Talks, People Listen - news.stocktradersdaily.com
Natera(NTRA) Shares Plunge 9.16% Amid Regulatory Hurdles - AInvest
What makes Natera Inc. stock price move sharplySafety First Trading Signals - beatles.ru
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Natera's $234M Trading Volume Ranks 433rd Amid Market Challenges - AInvest
Special master to decide whether Quinn Emanuel lawyers must contribute to $3M sanction - ABA Journal
Natera, Inc. (NTRA): A Bull Case Theory - Insider Monkey
Is Natera (NASDAQ:NTRA) Using Too Much Debt? - 富途牛牛
Quinn Emanuel Sanctioned For Ad Case 'Misrepresentations' - Law360
US judge rebukes law firm Quinn Emanuel, awards $3 million sanction in Guardant case - Reuters
Mike Brophy is regarded as one of Austin's best CFOs - The Business Journals
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.95%
1.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):